Why Is Abbott Stock Trading Higher On Thursday?

1. Abbott's Q4 sales rose to $10.97 billion, missing estimates. 2. Organic growth was 10.1%, excluding COVID testing sales. 3. Analyst expectations for strong growth in Diabetes Care and Medical Devices. 4. Abbott plans to improve operating margins by 150 basis points. 5. Stock price target raised by analysts, indicating positive outlook.